Navigation Links
OptiNose presents data on highly effective migraine treatment
Date:6/28/2008

BOSTON, MA Saturday June 28, 2008 OptiNose announced today that it presented important new data demonstrating the superior performance of its novel nasal drug delivery device with sumatriptan for the treatment of migraines. The Phase II results indicate that the drug-device combination achieves migraine relief as quickly and efficiently as injections without the discomfort, inconvenience and risk of needle-stick injuries. OptiNose presented the data at the Annual Scientific Meeting of the American Headache Society in Boston.

Headache relief was achieved in 74.3% and 83.8% of patients at 60 minutes and 120 minutes after administration, respectively, and 48.6% of patients remained pain free after 48 hours. The results were statistically significant when compared to the study's placebo group. The study also confirmed earlier Phase I results. In the Phase I study, the OptiNose powder nasal drug delivery device achieved the maximum sumatriptan concentration in the blood at a median time of 20 minutes after administration. This result was comparable to injections and much faster than other intranasal delivery technologies.

"We are excited to develop this new treatment for the approximately 30 million Americans who suffer from migraines," said Per Djupesland, M.D., Ph.D., the study's co-author and Chief Scientific Officer at OptiNose AS. "Our new device combination will offer patients a much-needed alternative to existing, slower-acting nasal inhalers and tablets and painful injections."

The user feedback from patients who participated in the study was also very encouraging. "The majority of the migraine patients found the device to be both comfortable and easy to use." said Dr Djupesland. "We believe that we can offer a unique therapy for migraine sufferers, combining fast relief, low side effects and high user compliance."

Unlike traditional nasal delivery devices, the unique design of the OptiNose device ensures that drug is delivered to target sites throughout the entire nasal cavity, achieving optimal dose delivery while avoiding the risk of drug deposition to the lungs.


'/>"/>

Contact: Per Djupesland, M.D., Ph.D.
+474-809-0610
OptiNose
Source:Eurekalert

Related medicine news :

1. International Association for Dental Research presents awards and fellowships
2. MIKE AND IKE(R) Lemonade Blends(TM) Presents $100,000 to Alexs Lemonade Stand Foundation
3. Journal STEM CELLS Presents 3rd Annual Young Investigator Award at International Stem Cell Symposium
4. The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation
5. Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia
6. CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
7. The febit science lounge presents: Webinar About Role of Non-Protein-Coding RNA in Human Genome Set for 11 a.m. EDT on June 12
8. American College of Rheumatology presents recommendations for rheumatoid arthritis therapy
9. Childrens Health and Fitness To Be Focus of ING Presents Marc Anthony Juntos en Concierto Series
10. Montana Center for Work Physiology and Exercise Metabolism presents firefighter health study
11. Montana Center for Work Physiology and Exercise Metabolism Presents Firefighter Health Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... The Workgroup for Electronic ... IT to create efficiencies in healthcare information exchange and a trusted advisor to the ... latest industry white paper, entitled Barriers to Adoption of the ERA and EFT ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... Driving Dynamics ... Safety Training Company by Training Industry Inc. as part of its mission to continually ... , Selection to the first annual 2017 Top 20 Health and Safety Training Companies ...
(Date:9/19/2017)... ... September 19, 2017 , ... Spain’s popular line of health ... coming soon to RonnieColemanNutrition.com. , ACPG Laboratories has been in business for ... brand reliant on the healing properties of plants, a proven science known as ...
(Date:9/19/2017)... Houston, TX (PRWEB) , ... September 19, 2017 , ... ... individual's risk of a heart attack by measuring their risk factors and calculating their ... Harvey and Irma were predicted the same way CVD is predicted today: an estimated ...
(Date:9/19/2017)... ... 19, 2017 , ... The Davidson Institute for Talent Development ... September 27 at a reception in Washington D.C. The recipients received $50,000, $25,000 ... , “I am honored to be a Davidson Fellow Laureate,” said Rishab Gargeya, ...
Breaking Medicine News(10 mins):
(Date:9/1/2017)... Ind. , Sept. 1, 2017  Explorers Like Us ... capture America,s greatest aural experiences — and deliver these experiences ... experience to help people feel and heal better. ... While nothing beats a ... and refresh your mind, Life Environments™ is the next best ...
(Date:8/31/2017)... Aug. 31, 2017 PM360,s annual Innovations ... to the latest innovations happening across the industry. Established ... to focus on providing a comprehensive look at the ... covers the most innovative companies, startups, divisions, products, services, ... "Everyone in this industry wants to ...
(Date:8/29/2017)... In a move that promises to exponentially ... veterinary practices of all sizes, Cubex LLC and The ... TITAN,s expertise in physical security, drug diversion investigations, staff ... "Every veterinary ... is at risk today," said TITAN founder and CEO, ...
Breaking Medicine Technology: